Tharimmune, Inc. (THAR)

Tharimmune Statistics

Total Valuation

Tharimmune has a market cap or net worth of $27.58 million. The enterprise value is $26.14 million.

Market Cap	27.58M
Enterprise Value	26.14M

Important Dates

The last earnings date was Thursday, August 14, 2025, before market open.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Tharimmune has 4.64 million shares outstanding. The number of shares has increased by 314.49% in one year.

Current Share Class	4.64M
Shares Outstanding	4.64M
Shares Change (YoY)	+314.49%
Shares Change (QoQ)	+11.84%
Owned by Insiders (%)	9.37%
Owned by Institutions (%)	18.00%
Float	3.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	69.51
P/TBV Ratio	76.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.91.

Current Ratio	1.17
Quick Ratio	1.04
Debt / Equity	0.91
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-658.23

Financial Efficiency

Return on equity (ROE) is -340.26% and return on invested capital (ROIC) is -204.70%.

Return on Equity (ROE)	-340.26%
Return on Assets (ROA)	-140.33%
Return on Invested Capital (ROIC)	-204.70%
Return on Capital Employed (ROCE)	-3,296.74%
Revenue Per Employee	n/a
Profits Per Employee	-$4.00M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +104.47% in the last 52 weeks. The beta is 1.19, so Tharimmune's price volatility has been higher than the market average.

Beta (5Y)	1.19
52-Week Price Change	+104.47%
50-Day Moving Average	2.16
200-Day Moving Average	1.84
Relative Strength Index (RSI)	66.81
Average Volume (20 Days)	28,804,529

Short Selling Information

The latest short interest is 61,821, so 1.33% of the outstanding shares have been sold short.

Short Interest	61,821
Short Previous Month	5,851
Short % of Shares Out	1.33%
Short % of Float	1.78%
Short Ratio (days to cover)	0.56

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.11M
Pretax Income	-8.88M
Net Income	-12.01M
EBITDA	n/a
EBIT	-12.11M
Earnings Per Share (EPS)	-$5.47

Balance Sheet

The company has $2.24 million in cash and $334,256 in debt, giving a net cash position of $1.91 million or $0.41 per share.

Cash & Cash Equivalents	2.24M
Total Debt	334,256
Net Cash	1.91M
Net Cash Per Share	$0.41
Equity (Book Value)	367,359
Book Value Per Share	0.09
Working Capital	367,359

Cash Flow

Operating Cash Flow	-9.73M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Tharimmune does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-314.49%
Shareholder Yield	-314.49%
Earnings Yield	-42.84%
FCF Yield	n/a

Analyst Forecast

The average price target for Tharimmune is $17.00, which is 185.71% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$17.00
Price Target Difference	185.71%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 28, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date	May 28, 2024
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	1